Eterna Regeneratives

Biomedical Engineering · Biomaterials

Overview

Eterna Regeneratives develops regenerative biomaterials for mineralisation and tissue regeneration, with initial applications in oral health, enamel repair and bone regeneration.

Funding and backers

Total raised
$4M
1 round on record
Latest round
$4M
Venture round · Sep 2026 · 1 mo ago
Team
11-50
employees, estimated range
Backers
1
Hoxton Ventures
The money's age
Fresh money
1 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 16 Raised a round Venture round $4M
Tractionpublic signals, read monthly
Web presence
top 36%
of 133.2M domains by links, Common Crawl
Funding rounds
RoundDateAmountInvestorsSource
Venture round Sep 2026 $4M — tmcnet.com
Backed byfrom the funds' portfolios and accelerator catalogs
Hoxton Ventures fund
Investors in similar startupsfunds that back the companies most like this one
SOSV
backs Tomtex
One Planet Capital Limited
backs Demeter Bio
Lowercarbon Capital
backs Macro Oceans
Horizons Ventures
backs erthos®
InMotion Ventures
backs Uncaged Innovations
Golden Ventures
backs erthos®
Similar startupsby what they do, their industry and backers
PondaEquity Crowdfunding $1.7M · 2 mo ago · Founded 2021 · 51-200 employees
Ponda is a biomaterials company developing novel textiles from truly regenerative fibres. We connect the regeneration of some of our most…
MYCOTEXFounded 2020
MYCOTEX® is a Biomaterial Technology Company. We engineer next-generation biomaterials for real world products.
erthos®
A climate technology company reducing global plastic dependency by scaling biomaterial adoption.
Uncaged InnovationsFounded 2020
Discover UNCAGED Innovations. We engineer premium, sustainable biomaterials and cruelty-free leather alternatives for global brands.
Sustanix
Sustanix develops novel biomolecules for advanced biomaterials, takes it from lab to industrial scale.
Tomtex
TômTex is a materials innovation company that is creating a new class of next-gen biomaterials.

Financials

Total raised
$4M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 $4M Details

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
Hoxton VenturesVia a fund
92 portfolio companies: Epsilon, Vatic, Vitesse and 89 more
Report a mistake